<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) features translocations linking c-myc to an Ig locus </plain></SENT>
<SENT sid="1" pm="."><plain>Breakpoints in the H chain locus (IgH) stand either close to J(H) or within switch regions and always link c-myc to the 3' IgH locus control region (3' LCR) </plain></SENT>
<SENT sid="2" pm="."><plain>To test the hypothesis that the 3' LCR alone was sufficient to deregulate c-myc, we generated mice carrying a 3' LCR-driven c-myc transgene and specifically up-regulating c-myc in B cells </plain></SENT>
<SENT sid="3" pm="."><plain>Splenic B cells from mice proliferated exaggeratedly in response to various signals had an elevated <z:mpath ids='MPATH_3'>apoptosis</z:mpath> rate but <z:mpath ids='MPATH_458'>normal</z:mpath> B220/IgM/IgD expression </plain></SENT>
<SENT sid="4" pm="."><plain>Although <z:hpo ids='HP_0000001'>all</z:hpo> Ig levels were lowered in vivo, class switching and Ig secretion proved <z:mpath ids='MPATH_458'>normal</z:mpath> in vitro </plain></SENT>
<SENT sid="5" pm="."><plain>Beginning at the age of 12 wk, transgenic mice developed clonal lymphoblastic <z:hpo ids='HP_0002665'>lymphomas</z:hpo> or diffuse anaplastic <z:hpo ids='HP_0011857'>plasmacytomas</z:hpo> with an overall incidence of 80% by 40 wk </plain></SENT>
<SENT sid="6" pm="."><plain>Lymphoblastic <z:hpo ids='HP_0002665'>lymphomas</z:hpo> were B220(+)IgM(+)IgD(+) with the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> "starry sky" appearance </plain></SENT>
<SENT sid="7" pm="."><plain>Gene expression profiles revealed broad alterations in the proliferation program and the Ras-p21 pathway </plain></SENT>
<SENT sid="8" pm="."><plain>Our study demonstrates that 3' IgH enhancers alone can deregulate c-myc and initiate the development of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>-like <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>The rapid and constant occurrence of <z:hpo ids='HP_0002665'>lymphoma</z:hpo> in this model makes it valuable for the understanding and the potential therapeutic manipulation of c-myc oncogenicity in vivo </plain></SENT>
</text></document>